Pharmaceuticals and personal care products in the environment: Regulatory drivers and research needs

QSAR and Combinatorial Science

Volumn 22, Issue 3, 2003, Pages 399-409

  Breton, Roger ^a   Boxall, Alistair ^b  

^a Cadmus Group Inc ^*  (Canada)

^b Cranfield Centre for EcoChemistry   (United Kingdom)

Author keywords

Pharmaceuticals and personal care products; QSARs; Regulatory drivers; Research needs

Indexed keywords

BIOMEDICAL EQUIPMENT; COMPUTATIONAL CHEMISTRY; ENVIRONMENTAL PROTECTION AGENCY; RISK ASSESSMENT;

'CURRENT; ENVIRONMENTAL RISKS; EUROPEAN UNION; PERSONAL CARE PRODUCTS; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; POTENTIAL EFFECTS; QSAR; REGULATORY DRIVERS; RESEARCH NEEDS; RISKS ASSESSMENTS;

VETERINARY MEDICINE;

COSMETIC; DRUG; VETERINARY DRUG;

CANADA; CONFERENCE PAPER; DRUG LEGISLATION; DRUG SURVEILLANCE PROGRAM; ECOTOXICITY; ENVIRONMENT; ENVIRONMENTAL PROTECTION; EUROPE; LAW; PRIORITY JOURNAL; RESEARCH; RISK ASSESSMENT; UNITED STATES;

EID: 0038515078     PISSN: 1611020X     EISSN: None     Source Type: Journal    
DOI: 10.1002/qsar.200390030     Document Type: Conference Paper

References (63)

1. Purdom, C. E., Hardiman, P. A., Bye, V. J., Eno, N. C., Tyler, C. R., and Sumpter, J. P., Estrogenic Effects of Effluents from Sewage Treatment Works, Chem. Ecol. 8, 275-285 (1994).
2. Baronti, C., Curini R., D'Ascenzo, G., Di Corcia, A., Gentili, A., and Samperi, R., Monitoring Natural and Synthetic Estrogens at Activated Sludge Sewage Treatment Plants and in a Receiving River Water, Environ. Sci. Technol. 34, 5059-5066 (2000).
3. Routledge, E. J., Sheahan, D., Desbrow, C., Sumpter, J. P., and Waldock, M., Identification of Estrogenic Chemicals in STW Effluent. 2. In Vivo Responses in trout and Roach, Environ. Sci. Technol. 32, 1559-1565 (1998).
4. McCracken, D. I., The Potential for Avermectins to Affect Wildlife, Vet. Parasitol. 48, 273-280 (1993).
5. Velagaleti, R., Behavior of Pharmaceutical Drugs (Human and Animal Health) in the Environment, Drug. Inform J. 31, 715-722 (1997).
6. Ternes, T. A., Occurrence of Drugs in German Sewage Treatment Plants and Rivers, Water Res. 31(11), 3245-3260 (1998).
7. Rogers, H. R., Sources Behaviour and Fate of Organic Contaminants During Sewage Treatment and in Sewage Sludges, Sci. Total Environ. 185, 3-26 (1996).
8. Daughton, C. G., and Ternes, T. A., Pharmaceuticals and Personal Care Products in the Environment: Agents of Subtle Change?, Environ. Health Perspect. 107(Supplement 6), 907-938 (1999).
9. Sedlak, D. L., Gray, J. L., and Pinkston, K. E., Understanding Micro Contaminants in Recycled Water, Environ. Sci. Technol. 34, 509A-515A (2000).
10. Kuch, H. M., and Ballschmiter K., Determination of Endocrine-Disrupting Phenolic Compounds and Estrogens in Surface and Drinking Water by HRGC-(NCI)-MS in the Picogram per Liter Range, Environ. Sci. Technol. 35, 3201-3206 (2001).
11. Al-Ahmad, A., Daschner, F. D., and Kummerer, K., Biodegradability of Cefotiam, Ciprofloxacin, Meropenem, Penicillin G., and Sulfametohoxazole and Inhibition of Wastewater Bacteria, Arch. Environ. Contam. Toxicol. 37, 158-153 (1999).
12. Bonner, M., and Wristen, K. G., The National Sewage Report Card (Number Two): Rating the Treatment Methods and Discharges of 21 Canadian Cities. Sierra Legal Defense Fund report, August 1999. Sierra Legal Defense Fund, Toronto, Ontario, Canada (1999).
13. Boxall, A. B. A., Blackwell, P. A., Cavello, R., Kay, P., and Tolls, J., The Sorption and Transport of a Sulfonamide Antibiotic in Soil Systems, Toxicol. Lett. 131, 19-28 (2002).
14. Yamagishi, T., Miyazaki, T., Horii, S., and Kaneko, S., Identification of Musk Xylene and Musk Ketone in Freshwater Fish Collected from the Tama River, Tokyo, Bull. Environ. Contam. Toxicol. 26, 656-662. (1981).
15. Buser H-R., Poiger, T., and Müller, M. D., Occurrence and Fate of the Pharmaceutical Drug Dichlofenac in Surface Waters: Rapid Photodegradation in a Lake, Environ. Sci. Technol. 32, 3449-3456 (1998).
16. Hartmann A., Alder, A. C., Koller, T., and Widmer, R. M., Identification of Fluoroquinolone Antibiotics as the Main Source of umuC Genotoxicity in Native Hospital Wastewater, Environ. Toxicol. Chem. 17(3), 377-382 (1998).
17. Ternes, T. A., Stumpf, M., Schuppert, B., and Haberer, K., Simultaneous Determination of Antiseptics and Acidic Drugs in Sewage and River, Vom. Wasser 90, 295-309 (1998).
18. Stumpf, M., Ternes, T. A., Haberer, K., Seel, P., and Baumann, W., Determination of Drugs in Sewage Treatment Plants and River Water, Vom Wasser 86, 291-303 (1996).
19. Kümmerer, K., Steger-Hartmann, T., and Meyer, M., Biodegradability of the Anti-Tumor Agent Ifosamide and Its Occurrence in Hospital Effluents and Communal Sewage, Water Res. 31 (11), 2705-2710 (1997).
20. Kümmerer K., Drugs in the Environment: Emission of Drugs, Diagnostic Aids and Disinfectants Into Waste by Hospitals in Relation to Other Sources - A Review, Chemosphere 45, 957-969 (2001).
21. Kolpin, D. W., Furlong, E., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. and Buxton, H. T., Pharmaceuticals, Hormones, and Other Organic Wasterwater Contaminants in US Streams, 1999-2000: A National Reconnaissance, Environ. Sci. Technol 36, 1202-1211 (2002).
22. Boxall, A. B. A., Fogg, L., Blackwell, P. A., Kay, P., and Pemberton, E. J., Review of Veterinary Medicines in the Environment. R&D Technical Report P6-012/8TR, UK Environment Agency, Bristol, UK, (2002).
23. Holm, J. V., Rügge, K., Bjerg, P. L., and Christensen, T. H., Occurrence and Distribution of Pharmaceutical Organic Compounds in the Groundwater Downgradient of a Landfill (Grindsted, Denmark), Environ. Sci. Technol. 29(5), 1415-1420 (1995).
24. Geyer H. J., Rimkus, G., Wolf, M., Attar, A., Steinburg, C., and Kettrup, A., Synthetic Nitro Musk Fragrances and Bromocyclen - New Environmental Chemicals in Fish and Mussels as Well as in Breast Milk and Human Lipids, Z. Umweltchem Ökotox 61(1), 8-17 (1994).
25. Halley, B. A., Jacob, T. A., and Lu, A. Y. H., The Environmental Impact of the Use of Ivermectin: Environmental Effects and Fate, Chemosphere 18: 1543-1563 (1989).
26. Bloom, R. A., and Matheson III, J. C., Environmental Assessment of Avermectins by the U.S. Food and Drug Administration, Vet. Parasitol. 48, 281-294 (1993).
27. van Wezel, A. P., and Jager, T., Comparison of Two Screening Level Risk Assessment Approaches for Six Disinfectants and Pharmaceuticals, Chemosphere 47, 1113-1128 (2002).
28. Arnold, S. F., Bergeron, J. M., Tran, D. Q., Collins, B. M., Vonier, P. M., Crews, D., Toscano Jr, W. A., and McLachlan, J. A., Synergism Responses of Steroidal Estrogens In Vitro (Yeast) and In Vivo (Turtles), Biochem. Biophys. Res. Commun. 235(2), 336-342 (1997).
29. Montague, P., Drugs in the Water. Rachel's Environment & Health Weekly #614. Available: gopher://ftp.std.com:70/11/periodicals/rachel/[cited 3 September 1998, (1998).
30. Roembke, J., Knacker, T. H, and Stahlschmidt-Allner, P., Study About Environmental Problems in Context with Drugs. F + E Vorhabens Nr. 106 04 121 Umweltbundesamt Berlin. German Report of the Research and Development Project no 106 04 121 of the Federal Ministry of Research and Development, Berlin, Germany (1996).
31. Ternes, T. A., Hirsch, R., Stumpf, M., Eggert, T., Schuppert, B. and Haberer, K., Identification and Screening of Pharmaceuticals Diagnostics and Antiseptics in the Aquatic Environment. German Report of the Federal Ministry of Education, Science, Research and Technology, (Ref no 02WU9567/3) Bonn, Germany, (1999).
32. Ayscough, N. J., Fawell, J., Franklin, G., and Young, W., Review of Human Pharmaceuticals in the Environment. R&D Technical Report P390, UK Environment Agency, Bristol, UK, 2000, 106 pp.
33. Halling-Sorensen, B., Nielsen, S. N., Lansky, P. F., Ingerslev, F., Holten Lutzhoft, H. C., and Jorgensen, S. E., Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment - A Review, Chemosphere 36(2), 357-393 (1998).
34. Servos, M. R., Bennie, D. T., Starodub, M. E., and Orr, J. C., Pharmaceuticals and Personal Care Products in the Environment: A Summary of Published Literature. NWRI Contribution No. 02-309, Environment Canada, National Water Research Institute, Burlington, ON, Canada, 2002, 211 pp.
35. Haley, C. J., Eirkson, C., Geil, S., and Mahanes,.B., US Food and Drug Administration Ecological Risk Assessments for Drugs Used in Aquaculture and in Terrestrial Animals, Vet. Hum. Toxicol. 40(Suppl 2), 52-55 (1998).
36. U.S. FDA (U.S. Food and Drugs Administration), Guidance for Industry: Environmental Impact Assessments (EIA's) for Veterinary Medicinal Products (VMP's)-Phase 1, Center for Veterinary Medicine, VICH GL6 Final Guidance. FDA, GD 89, Revision (March 7, 2001), 10 pp.
37. Eirkson, C., Harrass, M. C., Osborne, C. M., Sayre, P. G., and Zeeman, M. G., Environmental Assessment Technical Handbook. U.S. Food & Drug Administration, Washington, DC. March 1987, 28 Chapters (NTIS PB87-175345/AS).
38. U.S. FDA (U.S. Food and Drugs Administration), FDA Final Rule for Compliance with National Environmental Policy Act: Policy and Procedures. Federal Register 50 FR 16636, 21 CFR 25, 25 April 1995, (1995).
39. U.S. FDA (U.S. Food and Drugs Administration), Environmental Assessment Technical Assistance Handbook (FDA Center for Food Safety and Applied Nutrition, Environmental Impact Section, March 1987). NTIS PB87-175345, (1987).
40. U.S. FDA (U.S. Food and Drugs Administration), Guidance for Industry for the Submission of an Environmental Assessment in Human Drug Applications and Supplements, Center for Drug Evaluation and Research, November, CMC 6, (1995).
41. U.S. FDA (U.S. Food and Drugs Administration), Guidance for Industry - Environmental Assessment of Human Drug and Biologics Applications. Center for Drug Evaluation and Research & Center for Biologics Evaluation and Research, FDA, CMC 6, Revision 1 (July 1998). 42 pp.
42. CVMP (Committee for Veterinary Medicinal Products), Note for Guidance: Environmental Risk Assessment for Veterinary Medicinal Products other than GMO-containing and Immunological Products. EMEA/CVMP/O55/96-Final. European Agency for the Evaluation of Medicinal Products, London, (1997).
43. VICH (Veterinary International Co-operation on Harmonisation), Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products (VMPs) - Phase 1. VICH GL6 (Ecotoxicity Phase 1), June 2000, for implementation at Phase 7, (2000).
44. Tong, W., Perkins, R., Fang, H., Hong, H., Xie, Q., Branham, W., Sheehan, D.M., and Hason, J.F., Development of Quantitative Structure-Activity Relationships (QSARs) and Their Use for Priority Setting in the Testing Strategy for Endocrine Disruptors, Regulatory Res. Perspect. 1(3), 1-16 (2002).
45. Matthews, E. J., Contrera, J. F., A New Highly Specific Method for Predicting the Carcinogenic Potential of Pharmaceuticals in Rodents Using Enhanced MCASE QSAR-ES software, Regul. Toxicol. Pharmacol. 28, 242-264 (1998).
46. Matthews, E. J., Benz, R. D., and Contrera, J. F., Use of Toxicological Information in Drug Design, J. Mol. Graph. Model. 18, 605-615 (2000).
47. Mekenyan O, Ivanov J, Karabunarliev S, Bradbury S, Ankley G, Karcher W., A Computationally-Based Hazard Identification Algorithm that Incorporates Ligand Flexibility. 1. Identification of Potential Androgen Receptor Ligands, Environ Sci Technol. 31, 3702-3711 (1997).
48. Mekenyan O, Kamenska V, Serafimova R, Poellinger L, Brower A, Walker JD., Development and Validation of an Average Mammalian Estrogen Receptor-Based QSAR Model, SAR QSAR Environ Res, (2002) in press.
49. Hermens, J. L. M., P. Leeuwangh, and A. Musch., Quantitative Structure-Activity Relationships and Mixture Toxicity Studies of Chloro- and Alkylanilines at an Acute Lethal Toxicity Level to the Guppy (Poecilia reticulata), Ecotox. Environ. Saf. 8, 388-394, (1984).
50. Veith, G. D., D. J. Call, and L. T. Brooke., Structure-Toxicity Relationships for the Fathead Minnow, Pimephales promelas: Narcotic Industrial Chemicals, Can. J. Fish. Aquat. Sci. 40, 743-748 (1983).
51. Clements, R. G., and J. V. Nabholz., ECOSAR: A Computer Program for Estimating the Ecotocixity of Industrial Chemicals Based on Structure Activity Relationships. User's Guide. U.S. EPA, Office of Pollution Prevention and Toxics (7403), Washington DC. EPA-748-R-93-002, (1994).
52. Clements, R. G., J. V. Nabholz, M. Zeeman and C. M. Auer., The Application of Structure Activity Relationships (SARs) in the Aquatic Toxicity Evaluation of Discrete Organic Chemicals, SAR and QSAR in Environ. Res. 3, 203-215 (1995).
53. Könemann, H. Quantitative Structure-Activity Relationships in Fish Toxicity Studies. Part 1: Relationship for 50 Industrial Chemicals, Toxicol. 16, 209-221 (1981).
54. Veerhaar, H. J. M., C. J. van Leeuwen and J. L. M. Hermens., Classifying Environmental Pollutants. 1: Structure-Activity Relationships for Prediction of Aquatic Toxicity, Chemosphere 25, 471-491 (1992).
55. Verhaar, H. J. M., W. Mulder and J. L. M. Hermens., QSAR for Ecotoxicology. In: Overview of Structure-Activity Relationships for Environmental Endpoints, Part 1: General Outline and Procedure, Report of the EU-DG-XII Project QSAR for Predicting Fate and Effects of Chemicals in the Environment, Contract No. EV5V-CT92-0211, (1995).
56. EEC (European Economic Community), Technical Guidance Documents in Support of the Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and the Commission Regulation (EC) 1488/94 on Risk Assessment for Existing Substances. European Chemicals Bureau, Ispra, (1996).
57. Boethling, R. S., and Mackay, D., Handbook of Property Estimation Methods for Chemicals: Environmental and Health Sciences, Lewis Publishers, Boca Raton (USA), 2000, 481 pp.
58. Jaworska, J., S. Dimitrov, N. Nikolova and O. Mekenyan., Probabilistic Assessment of Biodegradability Based on Metabolic Pathways: Catabol System, SAR and QSAR in Environ. Res., 13 (2), 307-323 (2002).
59. Russom, C. L., Anderson, E. B., Greenwood, B. E., and Pilli, A., ASTER: An Integration of the AQUIRE Data Base and the QSAR System for Use in Ecological Risk Assessments, Sci. Total Environ. 109/110, 667-670 (1991).
60. Servos, M. et al. in preparation.
61. Tolls, J., Sorption of Veterinary Medicines: A Review, Environ. Sci. Technol. 35, 3397-3406 (2001).
62. Dimitrov, S., Koleva, Y., Lewis, M., Breton, R., Veith, G, and Mekenyan, O., Modeling Mode of Action of Industrial Chemicals: Application Using Chemicals on Canada's Domestic Substances List (DSL), QSAR and Combinatorial Science, Vol. 22(1), 5-17 (2003). [Part of the QSAR 2002 Proceedings]
63. Henschel, K-P., Wenzel, A., Diedrich, M., and Fliedner, A., Environmental Hazard Assessment of Pharmaceuticals, Regul. Toxicol. and Pharmacol. 25, 220-225 (1997).